Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
10.49
-0.30 (-2.78%)
At close: Oct 8, 2025, 4:00 PM EDT
10.52
+0.03 (0.29%)
After-hours: Oct 8, 2025, 4:24 PM EDT

Elicio Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
1725580---
Upgrade
Market Cap Growth
220.47%-31.39%----
Upgrade
Enterprise Value
1655572---
Upgrade
Last Close Price
10.525.108.34---
Upgrade
PB Ratio
93.29-4.867.04---
Upgrade
P/TBV Ratio
93.64-7.04---
Upgrade
Debt / Equity Ratio
8.13-2.300.610.84-2.880.03
Upgrade
Quick Ratio
2.231.531.320.900.494.53
Upgrade
Current Ratio
2.281.801.681.560.554.67
Upgrade
Return on Equity (ROE)
-60013.19%-170157.38%-346.95%-1170.93%-430.76%-136.60%
Upgrade
Return on Assets (ROA)
-123.26%-101.64%-89.70%-79.16%-92.36%-68.96%
Upgrade
Return on Capital (ROIC)
-259.55%-170.31%-128.82%-123.12%-130.00%-80.83%
Upgrade
Earnings Yield
-31.80%-94.42%-43.93%---
Upgrade
FCF Yield
-20.46%-67.60%-40.89%---
Upgrade
Buyback Yield / Dilution
-45.98%-141.35%-1500.08%97.93%-42.39%-172.21%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q